is retatrutide legal in the us FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still Phase II trials. While early studies have shown promising weight-loss results, Retatrutide (LY3437943) | GCGR/GLP-1R/GIPR Agonist

The resulting weight lossoften 15-20% of body weight with higher doses approved for obesity (Wegovy/Zepbound) and 5-10% with lower doses for diabetes (Ozempic/Mounjaro)can actually improve several cardiovascular risk factors

The muscle is the first thing to watch, and here is the part most men miss: strength fades about three times faster than size, so you lose the ability to do things well before the mirror tells you anything is wrong (Goodpaster, Journals of Gerontology, 2006)

This is where most diabetics inject

Increasingly, men are interested in the cosmetic and longevity dimensions of both TRT and peptide therapy

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies